Postmenopausal hormone therapy and mortality. - Wikidata - wikimedia - TriplyDB

Postmenopausal hormone therapy and mortality.

Postmenopausal hormone therapy and mortality.

http://www.wikidata.org/entity/Q34429144

about

Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties Debate: The potential role of estrogen in the prevention of heart disease in women after menopause Reduction of post injury neointima formation due to 17beta-estradiol and phytoestrogen treatment is not influenced by the pure synthetic estrogen receptor antagonist ICI 182,780 in vitro Estrogen receptor transcription and transactivation: Basic aspects of estrogen action.Pulse Wave Velocity in Postmenopausal Women Hypertension in menopausal women--a special case, for special treatment?Effect of pulsed estrogen therapy on hemostatic markers in comparison with oral estrogen regimen in postmenopausal women Synthesising licensing data to assess drug safety Oral contraceptives and periodontal diseases: rethinking the association based upon analysis of National Health and Nutrition Examination Survey data.Translesion synthesis past equine estrogen-derived 2'-deoxyadenosine DNA adducts by human DNA polymerases eta and kappa.The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial.Balance of beneficial and deleterious health effects of quinones: a case study of the chemical properties of genistein and estrone quinones.Black cohosh (Actaea racemosa) for the mitigation of menopausal symptoms: recent developments in clinical safety and efficacy.Modulatory effects of alpha- and gamma-tocopherols on 4-hydroxyestradiol induced oxidative stresses in MCF-10A breast epithelial cells.Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection.Recent advances. General medicine.Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms.Treatment of the menopause: the swinging pendulum.Relationship between benign prostatic hyperplasia and history of coronary artery disease in elderly men.Estrogen as a neuroprotectant in stroke.Modification of serum lipids and cardiovascular risk by estrogenic active compounds.Heart disease in women. Gender-specific statistics and prevention strategies for a population at risk.Oestrogen and vascular disease.Quantitative detection of 4-hydroxyequilenin-DNA adducts in mammalian cells using an immunoassay with a novel monoclonal antibody.Phytoestrogens as therapeutic alternatives to traditional hormone replacement in postmenopausal women.Migraine, menopause and hormonal replacement therapy.HRT to prevent cardiovascular disease. What studies show, how to advise patients.Redox cycling of catechol estrogens generating apurinic/apyrimidinic sites and 8-oxo-deoxyguanosine via reactive oxygen species differentiates equine and human estrogens.Ways to make "usual" and "successful" aging synonymous. Preventive gerontology.Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis.Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study.Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer.Hormonal breast augmentation: prognostic relevance of insulin-like growth factor-I.Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms.A comparison of clinical outcome studies among cholesterol-lowering agents.The medicalization of menopause: critique and consequences.Estrogens and lipids. Can HRT designer estrogens, and phytoestrogens reduce cardiovascular risk markers after menopause?

P2860

Q24626206-5ED75A9D-E2AF-4FAA-9233-45626DE8122E Q24649679-2C9D4409-4230-459F-9240-FB492584E861 Q24683330-ADC253C1-4BCF-483A-BC70-F19519DB80A5 Q24792867-88AAD0A4-108E-4A55-BA06-5D1285E8E33E Q24799163-26693E38-75B4-49FC-ABCC-456F6A212B3C Q24800814-71C2024C-160F-41E9-9B6A-FBB0C20AB478 Q27014049-D6920A84-5933-4F66-B81B-7655746657C3 Q28191800-80253594-F651-4FC6-BA80-B062C2B6BD69 Q28274641-EFC52D14-725E-4BCB-B88C-21093ABE7CB1 Q30908884-5307E3B2-23DC-4431-B07F-C8DAD778A99D Q30999993-B1516916-2A80-4B70-A74B-A10BD9367EE2 Q33242690-3DE3DCA6-9650-442C-ADF2-DDBAA637A3B2 Q33275630-F0F26951-D4EE-4EE3-AB44-6F9678362F7E Q33396534-D79578BF-1002-44A9-B41F-85B083DB8127 Q33508670-7C3171B7-08E5-4431-B8DF-47DDE397FBD8 Q33600031-63BC182A-A817-41A3-8CAE-C2713F75D2A4 Q33683302-BCACD90D-FEFD-4EE1-B4C2-3D8046C4D981 Q33791941-16CE5BB8-26E7-4A2F-B0FB-08CC94B04DBB Q33844950-523CD6E3-85A6-4DE8-AD77-1BD6038B4213 Q33876807-D1A7D585-C602-49B8-B028-AAA100DCD5C9 Q33895146-86882546-C571-4285-9762-3D0488F2D9F1 Q33898014-899D2BF2-D65B-4B40-BDD1-BB458F7F4D6C Q33947465-46FEE037-8009-4E10-804A-C13FCC1CE468 Q33949725-EA9FFFE7-464A-4FB2-B2CC-9349B0F7343F Q33951302-87E9C973-6471-447D-A9F6-F117926BDF43 Q33959481-880FAC61-D119-4E64-B350-53B20350BAAA Q34000992-B02D63BB-0028-4129-B238-A79CDB26EBA1 Q34039852-1AC411F5-2EEA-44F2-AF50-75CB8BE7FC29 Q34044754-CC812DFB-B6DB-456B-84C2-45AECEE580AB Q34069244-D0E08512-8828-420C-B87A-23C44C697840 Q34186865-E4577C10-8573-49B0-A6BB-9595AA856283 Q34328229-A32EEFE3-4CB3-444F-B96A-CA06048ADDE5 Q34343656-DB6AF12A-1F2E-4DB9-BC2A-DAD523F84E16 Q34434006-CF401393-9ED5-4376-9DF4-FD0C3A75880D Q34470227-F9CB3090-66F9-4A87-93FE-44ABE35E1445 Q34476118-111299BF-05FA-441C-A9E2-02810149E622 Q34483654-6FD70872-5496-48FB-BA10-E923395AF704 Q34495746-C0E5CD3B-7F24-40D1-A217-0ECE330C77D1 Q34504839-3E8D6322-F570-4C50-9611-7081C3697937 Q34505835-E1A818A4-E1E8-48A4-9C87-949958B86A89

P2860

Postmenopausal hormone therapy and mortality.

http://www.wikidata.org/entity/Q34429144

description

1997 nî lūn-bûn

@nan

1997 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Postmenopausal hormone therapy and mortality.

@ast

Postmenopausal hormone therapy and mortality.

@en

Postmenopausal hormone therapy and mortality.

@nl

type

label

Postmenopausal hormone therapy and mortality.

@ast

Postmenopausal hormone therapy and mortality.

@en

Postmenopausal hormone therapy and mortality.

@nl

prefLabel

Postmenopausal hormone therapy and mortality.

@ast

Postmenopausal hormone therapy and mortality.

@en

Postmenopausal hormone therapy and mortality.

@nl

P1433

Q34429144-88A58D18-427E-4870-99EB-1180FC17751F

P1476

Q34429144-DAA044C4-ABE7-4E1B-9763-E5F295C6AA2C

P2093

Q34429144-02258E70-D777-411B-B62D-5D45CF384C2C

Q34429144-108E8669-D3B1-4EE0-AC61-91C31C382ED5

Q34429144-21031880-8055-44B0-BD8C-C273F317FFDE

Q34429144-40C1CC71-FBCF-4D43-AB41-AB99F6D66032

Q34429144-4FCBB27E-AF31-4269-96C5-9F5E81DFE3BA

Q34429144-5BF9E690-5AAB-4136-9BDB-E519119B6A4F

Q34429144-81E3CA2B-2BA6-46A7-9923-4F8D6075D7F3

Q34429144-974BE9CE-2E9A-40A1-948A-AD09B152EC45

Q34429144-A9A71D29-3A1A-4B07-B41C-68DBF71FDE08

Q34429144-BF632254-9F96-4033-BE1C-2AFAEE31BFDD

P304

Q34429144-5D635556-E778-46F7-BC29-157F5C26BD11

P31

Q34429144-86DD2880-F02C-40FC-A268-3019998702EA

P356

Q34429144-8AC7A9AE-E72D-42B8-8D13-D09893B70667

P407

Q34429144-34AF5BC3-3E8D-4CCB-91C2-DC65156BFAB5

P433

Q34429144-AD3C32EC-04C2-4788-B1ED-C7D361027B44

P478

Q34429144-F3649CFA-C6C8-44C3-A825-4B49D29B1E0C

P50

Q34429144-2A81D798-A9FD-4AC9-BC38-74BE44BB0398

Q34429144-FEFBE0A7-25FA-4CFC-8054-268C15DF1151

P577

Q34429144-51A2FB40-2C7F-4557-BCB5-C23549FCE390

P698

Q34429144-5A5E7709-88C5-49AD-85F8-09E967FE76B2

P356

NEJM199706193362501

P1433

The New England Journal of Medicine

P1476

Postmenopausal hormone therapy and mortality

@en

P2093

Fuchs C

http://www.w3.org/2001/XMLSchema#string

Grodstein F

http://www.w3.org/2001/XMLSchema#string

Hankinson SE

http://www.w3.org/2001/XMLSchema#string

Hennekens CH

http://www.w3.org/2001/XMLSchema#string

Joffe M

http://www.w3.org/2001/XMLSchema#string

Manson JE

http://www.w3.org/2001/XMLSchema#string

Rosner B

http://www.w3.org/2001/XMLSchema#string

Speizer FE

http://www.w3.org/2001/XMLSchema#string

Stampfer MJ

http://www.w3.org/2001/XMLSchema#string

Willett WC

http://www.w3.org/2001/XMLSchema#string

P304

1769-1775

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM199706193362501

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

336

http://www.w3.org/2001/XMLSchema#string

P50

David J. Hunter

P577

1997-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9187066

http://www.w3.org/2001/XMLSchema#string